Effective April 2, 2025, all screeners previously provided by Sivadata Pty Ltd have been transferred to Kalkine Pty Ltd, a related entity of Sivadata Pty Ltd. You can access these screeners via the link https://kalkine.com.au/screeners.
PRNews

Avatar Capital Partners Closes Debut Real Estate Fund at JPY 15.2 billion in 12 months, and Welcomes Townsend as a Strategic Partner

Cision | Wed, Jul 09 2025 08:30 PM AEST

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

Fund Anchored by Townsend Group, Leading Pension Fund and Asia Family Offices

HONG KONG, July 9, 2025 /PRNewswire/ -- Avatar Capital Partners ("ACP"), an Asia-based asset management platform, today announced the final close of its inaugural real estate fund, ACP Real Estate Fund I (the "Fund") at JPY 15.2 billion (USD105 million). This Tokyo living sector focused fund has attracted significant interest, achieving an oversubscribed final close within just one year of its launch.

Townsend Group ("Townsend"), a leading advisor and partner to institutional investors globally, has made a strategic investment in the company. The Fund's final close is supported by Townsend, alongside one of the largest pension funds globally, as well as top-tier family offices and foundations throughout Asia.

The Fund will capitalize on off-market investment opportunities in Japan's thriving living sector, with a specific focus on acquiring high-quality multifamily assets in prime Tokyo locations. This strategy leverages strong underlying fundamentals, including urban population growth, robust rental demand, and accelerating rental growth.

"We are pleased to announce the successful close of our inaugural fund, surpassing our target despite a challenging fundraising environment," said Ryuta Ueda, Founding Partner of ACP. "We are also thrilled to welcome Townsend as our strategic partner. Their profound capital markets expertise and global institutional perspective provide invaluable access to both financial and intellectual capital, significantly accelerating ACP's growth trajectory." Ueda continued, "With Asia's living sector expanding rapidly, we see strong demand for innovative housing solutions. The Fund has already acquired five premium multifamily properties in Central Tokyo and has a deep pipeline of interesting opportunities including near-term acquisition of five additional assets. We will continue to partner with leading local Japanese conglomerates to address the evolving needs of future living."

Angel Li, Founding Partner of ACP, commented, "The global real estate sector is transitioning into a phase of recovery and expansion, with the Asia-Pacific region offering compelling opportunities. Japan stands out due to its attractive financing conditions and inflation-driven growth potential. Characterized by favorable demographic tailwinds and sustained rental demand, Tokyo's living sector offers a compelling investment landscape."

With the team co-led by Ryuta Ueda and Ronald Chiu, Founding Partner of ACP, and supported by a robust network of seasoned operating partners, the Fund is well-positioned to thrive in this competitive market and generate exceptional value to our investors.

"As the advisor to a consortium of global investors – including some of the largest sovereign and pension plans pursuing strategic stakes in leading investment and operating platforms, we are delighted to partner with ACP.  We have strong conviction in ACP team's strategy and the significant potential of Japan's dynamic living sector." said Anthony Frammartino, CEO and Chairman of Townsend.

About Avatar Capital Partners

Avatar Capital Partners (ACP) is an Asia-based asset management platform with a unique edge in alternative investments. The firm combines a disciplined investment philosophy with a focus on fundamental investing and sustainable solutions, positioning it to deliver exceptional results across market cycles. ACP's expertise in thematic investing and market insights has established it as a trusted partner in the private equity space. For more information, please visit: www.avatarcp.com

About Townsend Group
Townsend Group is a provider of global real estate and real asset investment advisory services. Townsend offers complementary investment management, advisory, and capital solutions via primary funds, secondaries, co-investments and direct investments. Townsend is an adviser to global public and private pension plans, insurers, sovereign wealth funds, endowments and foundations. Townsend has been advising and managing real estate portfolios for four decades and across multiple market cycles. As of September 30, 2024, Townsend had assets under management of $19.3B and as of March 31, 2024, provided advisory services to clients who had real estate/real asset allocations exceeding $237.9B. For more information, visit: www.townsendgroup.com

PRNews

NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports

NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE ...

Cision | Wed, Jul 09 2025 10:55 PM AEST

Read More
World News

As the Planet Warms: 10 Ways Lawns Offer a Sustainable Path Forward

With global warming intensifying and 2024 marking the warmest year on record, the need for climate-conscious landscaping practices has never been ...

3BL | Wed, Jul 09 2025 10:45 PM AEST

Read More
PRNews

MAMMOTION's Biggest U.S. Wire-Free Robot Mower Sale Yet: Up to 32% Off This Prime Day

Unlock Smart, Wire-Free Lawn Care with Up to $500 in Savings on Amazon from July 7–13 LOS ANGELES, July 9, 2025 /PRNewswire/ -- ...

Cision | Wed, Jul 09 2025 10:45 PM AEST

Read More
PRNews

GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability

PISCATAWAY, N.J., July 9, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing ...

Cision | Wed, Jul 09 2025 10:32 PM AEST

Read More
PRNews

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

SHANGHAI, NANJING, China and SAN FRANCISCO, July 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused ...

Cision | Wed, Jul 09 2025 10:18 PM AEST

Read More